Trademark Overview
On Friday, December 6, 2024, a trademark application was filed for PROJECT ACT with the United States Patent and Trademark Office. The USPTO has given the PROJECT ACT trademark a serial number of 98889788. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, June 5, 2025. This trademark is owned by Breakthrough T1D. The PROJECT ACT trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Charitable fundraising services for promoting research and education relating to type 1 diabetes; Accepting and administering monetary charitable contributions to fund medical research; Financial services, namely, funding research in the field of type 1 diabetes
Promoting public awareness of type 1 diabetes, type 1 diabetes research, and treatments, preventions and cures for type 1 diabetes, by means of public advocacy
Providing information in the field of prevention, screening, diagnosis and treatment of type 1 diabetes; providing information in the field of prevention, screening, diagnosis and treatment of type 1 diabetes via a website; providing health information; providing health information in the field of type 1 diabetes; Medical information services, namely, developing guidelines for clinical trial models, recruitment, and endpoints
Providing information about medical research; providing information about medical research in the field of type 1 diabetes; Providing information about medical and scientific research via a website; Providing medical and scientific research information in the field of clinical trials
